Gubra A/S (CPH:GUBRA)

Revenue by Product

Financials in millions DKK. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Pre-clinical Contract Research	220.22M
Pre-clinical Contract Research Growth	30.65%
Discovery and Partnership	45.52M
Discovery and Partnership Growth	24.90%

Revenue by Geography

Financials in millions DKK. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
United States	101.00M
United States Growth	17.44%
Europe	65.63M
Europe Growth	109.84%
Germany	49.00M
Germany Growth	11.36%
Denmark	43.00M
Denmark Growth	30.30%
North America	204.00K
North America Growth	-92.67%
Other	6.91M
Other Growth	-13.10%